Have a website account?
Log In
or
Register
for exclusive website content.
Subscribe
to AOB Journal
Advanced Search
Home
Journal Info
About
aob
Editor-in-Chief
Editorial Board
Manuscript Info
Online Submission
Author Instruction
Publication Ethics
Reference Style
Submit Multimedia Files
Online Review
Current Issue
Archives
Publish Ahead of Print
News
Home
/
About the Journal
/
Editorial Team
Editorial Team
The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed below and the roles and responsibilities of the editorial team are available at:
https://www.amegroups.com/pages/journal-management#content-title
.
Editor-in-Chief
Yongshui Fu, MD, PhD
Guangzhou Blood Center, Guangzhou, China
Associate Editor-in-Chief
Chengyao Li, PhD
Department of Transfusion Medicine, Southern Medical University, Guangzhou, China
Editorial Board
Robert Flower, PhD, FFSc (RCPA)
National Leader Product Safety Research, Australian Red Cross Blood Service and Adjunct Professor at Queensland University of Technology, Brisbane, Australia
Paul M. Ness, MD
Director of the Transfusion Medicine Division at The Johns Hopkins Hospital and Professor of Pathology, Medicine, and Oncology at The Johns Hopkins University School of Medicine in Baltimore, Maryland USA
Frank Tacke, MD, PhD
Professor of Medicine, Department of Gastroenterology, Metabolic Diseases and Intensive Care Medicine, University Hospital Aachen, Germany
Maurizio Chiriva-Internati, PhD, D BSc
Department of Internal Medicine, Division of Hematology & Oncology and Pulmonary and Critical Care Medicine, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
Jeffrey Mc Cullough, MD
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA
Thierry Burnouf, PhD
Professor, Director of the Graduate Institute of Biomedical Materials and Tissue Engineering, and of the International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
Albert Farrugia BSc PhD (Edin)
Adjunct Professor, School of Surgery, Faculty of Medicine and Surgery, The University of Western Australia, Perth, Australia
Ulrich J. Sachs,MD, PhD
Associate Professor of Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Germany
Jean-Pierre Allain, MD, PhD, FRCPath
Professor of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, UK
Daniel Candotti, PhD
National Institute of Blood Transfusion, Department of Blood transmissible Agents, National Reference Centre for B & C Hepatitis and HIV in Transfusion, Paris, France
Joan Cid, MD, PhD
Department of Hemotherapy and Hemostasis, ICMHO, Hospital Clinic, Villarroel, Barcelona, Catalonia, Spain
Seyed Mohammad Jazayeri, MD, PhD
Associate Professor of Virology, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Iran
Chun-jen Liu, MD, PhD
Graduate Institute of Clinical Medicine, Hepatitis Research Center and Department of Internal Medicine, National Taiwan University College of Medicine, Taiwan
Kenrad E. Nelson, MD
Professor of Epidemiology, International Health and Medicine, Johns Hopkins University Medical Institutions, Baltimore, MD, USA
Sentot Santoso, MD
Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany
Man-Fung Yuen, MD, PhD
University of Hong Kong, Queen Mary Hospital, Hong Kong
Brian Kay, DO
Providence St. Joseph Medical Center and Providence Holy Cross Medical Center, Los Angeles, CA, USA
Piotr Radziwon, MD, PhD
General Director of Regional Centre for Transfusion Medicine in Bialystok, Bialystok, Poland; Associate Professor at the Department of Haematology, Medical University of Bialystok, Bialystok, Poland
Laurence Corash, MD
Chief Scientific Officer, Cerus Corporation, Concord, CA, USA
Section Editors
Zimu Gong, MD (Hematological Malignancies)
Department of hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of hematology, Shengjing hospital of China Medical University, Shenyang, China
Runzhe Chen, MD (Hematology and Oncology)
Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States; Department of Hematology and Oncology, Zhongda Hospital of Southeast University, Nanjing, Jiangsu Province, P.R. China
Yanli Ji, MD, PhD (Transfusion Medicine)
Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, China
Tingting Li, PhD (Transfusion Medicine)
Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
Xi Tang, PhD (Clinical Medicine)
Department of Transfusion medicine, Southern medical University, Guangzhou, China
Ling Wei, MD (Transfusion Medicine)
Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, China
Wenjie Xia, MD, PhD (Clinical Immunology and Transfusion Medicine)
Institute of Clinical Immunology and Transfusion Medicine, Guangzhou Blood Center, Guangzhou, China
Ru Xu (Preclinical Medicine)
Research fellow of Institute of Transfusion, Guangzhou Blood Center, Guangzhou, China
Peipei Xu, MD (Hematologic Oncology)
Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
Xiuzhang Xu, MD (Transfusion Medicine)
Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China
Managing Editors
Grace Li
Editorial Office
Eunice X. Xu
Editorial Office, Annals of Blood
Senior Editor
Jessie S. Zhong
Editorial Office, Annals of Blood
Suki X. Tang
Editorial Office, Annals of Blood